The Prognostic Value of High-Sensitive Troponin i in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables

Cardiology (Switzerland)

Volumn 132, Issue 1, 2015, Pages 1-8

  Carda, Rocío ^e   Aceña, Álvaro ^e   Pello, Ana ^e   Cristóbal, Carmen ^a,b   Tarín, Nieves ^c   Huelmos, Ana ^d   Alonso, Joaquín ^a,b   Asensio, Dolores ^f   Lorenzo, Óscar ^e,g   Martín Ventura, José Luis ^e,g   Blanco Colio, Luis ^e   Farré, Jerónimo ^e,g   López Bescós, Lorenzo ^b   Egido, Jesús ^g,h   Tuñón, José ^e,g  

^a HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

^c HOSPITAL DE MÓSTOLES   (Spain)

^d HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^e 28400 Madrid   (Spain)

^f Department of Biochemistry ^*  (Spain)

^g UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^h INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Biomarkers; High sensitive troponin; Prognosis; Stable coronary artery disease

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; CLOPIDOGREL; DIURETIC AGENT; TROPONIN I; ANTICOAGULANT AGENT; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGING; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE CORONARY ARTERY DISEASE; BLOOD; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; STATISTICAL MODEL;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; BIOMARKERS; CORONARY ARTERY DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TROPONIN I;

EID: 84942194741     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000381259     Document Type: Article

References (33)

1. Apple FS, Collinson PO: Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012; 58: 54-61.
2. Jaffe AS, Ordonez-Llanos J: High-sensitivity cardiac troponin: from theory to clinical practice. Rev Esp Cardiol 2013; 66: 687-691.
3. Ndrepepa G, Braun S, Mehilli J, Birkmeier KA, Byrne RA, Ott I, Hosl K, Schulz S, Fusaro M, Pache J, Hausleiter J, Laugwitz KL, Massberg S, Seyfarth M, Schomig A, et al: Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. Am Heart J 2011; 161: 68-75.
4. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD: Third universal definition of myocardial infarction. J Am Coll Cardiol 2012; 60: 1581-1598.
5. De Antonio M, Lupon J, Galan A, Vila J, Zamora E, Urrutia A, Diez C, Coll R, Altimir S, Bayes-Genis A: Head-to-head comparison of high-sensitivity troponin T and sensitivecontemporary troponin I regarding heart failure risk stratification. Clin Chim Acta 2013; 426: 18-24.
6. Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O'Connor CM, Felker GM: Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol 2010; 56: 1071-1078.
7. Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, Angelici L, Barlera S, Parrinello G, Maggioni AP, Tognoni G, Cohn JN: Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007; 116: 1242-1249.
8. Xu RY, Zhu XF, Yang Y, Ye P: High-sensitive cardiac troponin T. J Geriatr Cardiol 2013; 10: 102-109.
9. Everett BM, Cook NR, Magnone MC, Bobadilla M, Kim E, Rifai N, Ridker PM, Pradhan AD: Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study. Circulation 2011; 123: 2811-2818.
10. Sato Y, Yamamoto E, Sawa T, Toda K, Hara T, Iwasaki T, Fujiwara H, Takatsu Y: Highsensitivity cardiac troponin T in essential hypertension. J Cardiol 2011; 58: 226-231.
11. De Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, McGuire DK: Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010; 304: 2503-2512.
12. De Filippi CR, de Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, Seliger SL: Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010; 304: 2494-2502.
13. Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, Hoogeveen RC, Liu X, Astor BC, Mosley TH, Folsom AR, Heiss G, Coresh J, Ballantyne CM: Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011; 123: 1367-1376.
14. Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B: Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality. Circulation 2007; 116: 1907-1914.
15. Omland T, Pfeffer MA, Solomon SD, de Lemos JA, Rosjo H, Saltyte Benth J, Maggioni A, Domanski MJ, Rouleau JL, Sabatine MS, Braunwald E: Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol 2013; 61: 1240-1249.
16. Alcalai R, Planer D, Culhaoglu A, Osman A, Pollak A, Lotan C: Acute coronary syndrome versus nonspecific troponin elevation: clinical predictors and survival analysis. Arch Intern Med 2007; 167: 276-281.
17. Tunon J, Blanco-Colio L, Cristobal C, Tarin N, Higueras J, Huelmos A, Alonso J, Egido J, Asensio D, Lorenzo O, Mahillo-Fernandez I, Rodriguez-Artalejo F, Farre J, Martin-Ventura JL, Lopez-Bescos L: Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease. Am J Cardiol 2014; 113: 434-440.
18. Gomez-Doblas JJ, Muniz J, Martin JJ, Rodriguez-Roca G, Lobos JM, Awamleh P, Permanyer-Miralda G, Chorro FJ, Anguita M, Roig E: Prevalencia de fibrilacion auricular en Espana. Resultados del estudio OFRECE. Rev Esp Cardiol 2014; 67: 259-269.
19. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E: The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000; 284: 835-842.
20. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum A, Flather MD, Fox KA: A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291: 2727-2733.
21. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, et al: 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the Management of Stable Coronary Artery Disease of the European Society of Cardiology. Eur Heart J 2013; 34: 2949-3003.
22. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire DK, Wians F, Sabatine MS, Morrow DA, de Lemos JA: Prevalence and determinants of troponin T elevation in the general population. Circulation 2006; 113: 1958-1965.
23. De Lemos JA: Increasingly sensitive assays for cardiac troponins: a review. JAMA 2013; 309: 2262-2269.
24. Eggers KM, Venge P, Lindahl B, Lind L: Cardiac troponin I levels measured with a highsensitive assay increase over time and are strong predictors of mortality in an elderly population. J Am Coll Cardiol 2013; 61: 1906-1913.
25. Eggers KM, Al-Shakarchi J, Berglund L, Lindahl B, Siegbahn A, Wallentin L, Zethelius B: High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men. Am Heart J 2013; 166: 541-548.
26. Korosoglou G, Lehrke S, Mueller D, Hosch W, Kauczor HU, Humpert PM, Giannitsis E, Katus HA: Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart 2011; 97: 823-831.
27. Beatty AL, Ku IA, Christenson RH, DeFilippi CR, Schiller NB, Whooley MA: High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study. JAMA Intern Med 2013; 173: 763-769.
28. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, Pfeffer MA, Braunwald E: A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009; 361: 2538-2547.
29. Wang TJ, Wollert KC, Larson MG, Coglianese E, McCabe EL, Cheng S, Ho JE, Fradley MG, Ghorbani A, Xanthakis V, Kempf T, Benjamin EJ, Levy D, Vasan RS, Januzzi JL: Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation 2012; 26: 1596-1604.
30. Agewall S, Giannitsis E, Jernberg T, Katus H: Troponin elevation in coronary versus noncoronary disease. Eur Heart J 2011; 32: 404-411.
31. Durante A: The value of elevated high-sensitive troponin T. Am Heart J 2011; 161:e33.
32. Wijns W, Crea F: Elevated troponin in stable coronary artery disease: the sound of silence. Heart 2011; 97: 785-786.
33. Eggers KM, Lagerqvist B, Oldgren J, Venge P, Wallentin L, Lindahl B: Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome. Am Heart J 2008; 156: 588-594.